
Tandem Diabetes Care introduces next-gen automated insulin delivery algorithm
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in the U.S.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in the U.S.

Ypsomed and CamDiab today announced the launch of the mylife CamAPS FX app for automated insulin delivery on iOS platforms.

CAESAREA, Israel, March 17, 2025 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it has received a Notice of Allowance for its invention titled “Cryogenic System Connector” from the China National Intellectual Property Administration.

Bausch + Lomb announced today that it launched Arise, its intelligent, cloud-based lens-fitting system, in the U.S.

MENLO PARK, Calif., March 17, 2025 /PRNewswire/ — Subtle Medical, a global leader in AI-powered medical imaging enhancement, announced today that SubtleHD™ has received CE Mark certification, officially launching the solution in Europe. The software is designed to dramatically improve MRI image quality, reduce scan times by up to 80%, and optimize radiology workflows.

The Greenland shark likes to stick around, with some estimates suggesting a lifespan of more than 500 years – and a new study of the shark’s DNA has given researchers vital clues to the secret of its longevity.

A decade of studies provide a growing evidence base that increasing the power of the brain’s gamma rhythms could help fight Alzheimer’s, and perhaps other neurological diseases.

Lifeward (Nasdaq:LFWD) announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk 7.

Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic navigation.

Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding.